10 Overlooked Healthcare Stocks to Invest in

7. Bausch Health Companies Inc. (NYSE:BHC)

Number of Hedge Fund Holders: 28 

Bausch Health Companies Inc. (NYSE:BHC) is a global specialty pharmaceutical and medical device company focused on eye health, gastroenterology, neurology, and dermatology.

In Q2 2025, Bausch Health Companies Inc. (NYSE:BHC) reported strong operational results, with revenues of $2.53 billion, up 5.3% year-over-year, and net income surging 1,380% from the same quarter in 2024. Earnings per share rose to $0.40, surpassing analyst expectations. This performance reflects successful debt reduction initiatives, including plans to repay $900 million via senior notes redemption and loan repayments, strengthening the firm’s financial position.

Bausch Health Companies Inc. (NYSE:BHC) is also expanding its pipeline and portfolio through strategic acquisitions. The recent acquisition of DURECT Corporation enhances its hepatology segment with a focus on liver disease therapies, signaling a shift toward higher-growth therapeutic areas.

Investor sentiment has been positively influenced by an FDA breakthrough designation, boosting share performance amid market volatility.